Stem definition | Drug id | CAS RN |
---|---|---|
corticosteroids, except prednisolone derivatives | 4569 | 72590-77-3 |
None
Property | Value | Reference |
---|---|---|
S (Water solubility) | 0.23 mg/mL | Bocci G, Oprea TI, Benet LZ |
Date | Agency | Company | Orphan |
---|---|---|---|
Feb. 28, 1997 | FDA | FOUGERA PHARMS |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
C-reactive protein | 55.22 | 36.82 | 15 | 1817 | 4867 | 63482323 |
Deep vein thrombosis postoperative | 46.59 | 36.82 | 16 | 1816 | 11353 | 63475837 |
Lip dry | 41.78 | 36.82 | 16 | 1816 | 15454 | 63471736 |
Autoimmune disorder | 40.15 | 36.82 | 16 | 1816 | 17161 | 63470029 |
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
C-reactive protein | 58.29 | 50.19 | 15 | 1820 | 4964 | 79737589 |
Deep vein thrombosis postoperative | 51.02 | 50.19 | 16 | 1819 | 10736 | 79731817 |
None
Source | Code | Description |
---|---|---|
ATC | D07AB11 | DERMATOLOGICALS CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS CORTICOSTEROIDS, PLAIN Corticosteroids, moderately potent (group II) |
FDA MoA | N0000175450 | Corticosteroid Hormone Receptor Agonists |
FDA EPC | N0000175576 | Corticosteroid |
MeSH PA | D000893 | Anti-Inflammatory Agents |
CHEBI has role | CHEBI:35472 | anti-inflammatory drugs |
CHEBI has role | CHEBI:49167 | anti-asthmatic drugs |
CHEBI has role | CHEBI:50857 | anti-allergic drugs |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
CHEBI has role | CHEBI:88188 | allergenic drug |
None
None
None
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Glucocorticoid receptor | Nuclear hormone receptor | AGONIST | CHEMBL | CHEMBL |
ID | Source |
---|---|
4025074 | VUID |
N0000179153 | NUI |
4017941 | VANDF |
4021000 | VANDF |
4025074 | VANDF |
CHEBI:31675 | CHEBI |
CHEBI:17650 | CHEBI |
CHEMBL1200953 | ChEMBL_ID |
C033014 | MESH_SUPPLEMENTAL_RECORD_UI |
DB14543 | DRUGBANK_ID |
O6550D6K3A | UNII |
DB00741 | DRUGBANK_ID |
219083 | RXNORM |
17268 | MMSL |
2500 | MMSL |
4837 | MMSL |
4839 | MMSL |
9839 | MMSL |
d00254 | MMSL |
002147 | NDDF |
006405 | NDDF |
126150008 | SNOMEDCT_US |
16602005 | SNOMEDCT_US |
396458002 | SNOMEDCT_US |
C0063076 | UMLSCUI |
C0020268 | UMLSCUI |
636398 | PUBCHEM_CID |
38 | INN_ID |
5754 | PUBCHEM_CID |
D006854 | MESH_DESCRIPTOR_UI |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
PANDEL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10337-153 | CREAM | 1 mg | TOPICAL | NDA | 22 sections |
PANDEL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 62559-325 | CREAM | 1 mg | TOPICAL | NDA | 22 sections |